What happens when groundbreaking cancer research threatens the status quo?

In this episode, Dr. Dan Rubin sits down with Sylvie Beljanski—author, lawyer, and daughter of the late Dr. Mirko Beljanski—to uncover a powerful story of scientific discovery, political suppression, and resilience.

Sylvie shares how her father's innovative research into plant-based compounds that selectively target cancer cells was nearly lost forever.

From the shocking arrest of her parents to rebuilding the research through the Beljanski Foundation, this conversation dives into science, courage, and legacy—plus the latest clinical trials exploring stem cells, RNA fragments, and natural compounds with profound potential in integrative oncology.

Topics covered include:

Her father's early discovery of DNA destabilization and environmental carcinogens

 Natural compounds that target cancer cells without harming healthy cells

 Research on ovarian, prostate, pancreatic, and breast cancer stem cells

Clinical trials on RNA extracts that support bone marrow during chemotherapy

 Building the Beljanski Foundation and honoring a legacy

Chapters

00:00 – Introduction

01:00 – Sylvie’s legal background & the call that changed everything

04:00 – Her father's discovery: DNA destabilization and cancer

07:00 – Plant extracts that selectively inhibit cancer cell replication

09:00 – Mitterrand’s prostate cancer recovery

11:00 – Rebuilding the science in the U.S.

13:00 – Clinical insights with Columbia University & CTCA

17:30 – Cancer stem cells: the next frontier

19:00 – Golden ginkgo extract & angiogenesis

21:00 – RNA fragments for immune support during chemotherapy

23:30 – Clinical trials and collaborative research

24:30 – The power of community and legacy

26:00 – Where to find Sylvie and her work

🌐 Learn more:

    •    www.beljanski.org (https://www.beljanski.org/)

    •    www.maisonbeljanski.com (https://www.maisonbeljanski.com/)